Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus

Nature Neuroscience

Volumn 8, Issue 9, 2005, Pages 1139-1141

  Makara, Judit K ^a   Mor, Marco ^b   Fegley, Darren ^c   Szabó, Szilárd I ^a   Kathuria, Satish ^c   Astarita, Giuseppe ^c   Duranti, Andrea ^d   Tontini, Andrea ^d   Tarzia, Giorgio ^d   Rivara, Silvia ^b   Freund, Tamás F ^a   Piomelli, Daniele ^c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF URBINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ENDOCANNABINOID; ESTERASE INHIBITOR; UNCLASSIFIED DRUG; URB 597; URB 602; URB 754; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ACYLGLYCEROL LIPASE; ARACHIDONIC ACID DERIVATIVE; ENZYME INHIBITOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROLYSIS; NERVE CELL PLASTICITY; NERVE ENDING; NEUROTRANSMISSION; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RETROGRADE NERVE FIBER TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; CELL MEMBRANE POTENTIAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HELA CELL; HIPPOCAMPUS; IN VITRO STUDY; METABOLISM; METHODOLOGY; NERVE CELL INHIBITION; PATCH CLAMP; PHYSIOLOGY; RAT;

ANIMALS; ARACHIDONIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; ENZYME INHIBITORS; GLYCERIDES; HELA CELLS; HIPPOCAMPUS; HUMANS; HYDROLYSIS; MEMBRANE POTENTIALS; MONOACYLGLYCEROL LIPASES; NEURAL INHIBITION; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; SIGNAL TRANSDUCTION;

EID: 25844440525     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1521     Document Type: Article

References (14)

1. Freund, T.F., Katona, I. & Piomelli, D. Physiol. Rev. 83, 1017-1066 (2003).
2. Wilson, R.I. & Nicoll, R.A. Nature 410, 588-592 (2001).
3. Ohno-Shosaku, T., Maejima, T. & Kano, M. Neuron 29, 729-738 (2001).
4. Wilson, R.I., Kunos, G. & Nicoll, R.A. Neuron 31, 453-462 (2001).
5. Piomelli, D. Nat. Rev. Neurosci. 4, 873-884 (2003).
6. Cravatt, B.F. et al. Nature 384, 83-87 (1996).
7. Dinh, T.P. et al. Proc. Natl. Acad. Sci. USA 99, 10819-10824 (2002).
8. Kim, J. & Alger, B.E. Nat. Neurosci. 7, 697-698 (2004).
9. Porter, A.C. et al. J. Pharmacol. Exp. Ther. 301, 1020-1024 (2002).
10. Huang, C.C., Chen, Y.L., Lo, S.W. & Hsu, K.S. Mol. Pharmacol. 61, 578-585 (2002).
11. Hohmann, A.G. et al. Nature 435, 1108-1112 (2005).
12. Kathuria, S. et al. Nat. Med. 9, 76-81 (2003).
13. Krantz, A. et al. J. Med. Chem. 33, 464-479 (1990).
14. Hudson, H.F. et al. International patent application PCT WO 00/40247 (2000).